❓ Hon Barry House asks about the expenditure of the $72 million science budget, particularly regarding biotechnology funding. Hon Kim Chance provides figures for spending in 2006-07 and 2007-08, and confirms biotechnology is funded from the science budget.
AnsweredQoN 1020Legislative Council
QuestionView source ↗
SCIENCE AND INNOVATION - STATE BUDGET
In reference to the 2006-07 to 2009-10 $72 million science budget - (1) How much of this money has been spent so far? (2) How much of the $18 million allocated for 2006-07 was spent? (3) How much of the $18 million allocated for 2007-08 has been spent so far? (4) Is biotechnology funded from the science budget? (5) If so, what commitments have been funded so far? (6) If not, which section of the budget allocates funds to biotechnology? Hon KIM CHANCE
In reference to the 2006-07 to 2009-10 $72 million science budget - (1) How much of this money has been spent so far? (2) How much of the $18 million allocated for 2006-07 was spent? (3) How much of the $18 million allocated for 2007-08 has been spent so far? (4) Is biotechnology funded from the science budget? (5) If so, what commitments have been funded so far? (6) If not, which section of the budget allocates funds to biotechnology? Hon KIM CHANCE
AnswerView source ↗
I thank the member for some notice of this question. (1) $4 358 320. (2) $2 900 000. (3) $1 458 320. (4) Yes. (5) Biotechnology strategy, $4 170 000; clinical trials network, $9 946 000; and neurotrauma research program, $8 000 000 - making a total of $22 116 000. (6) Not applicable.
(1) How much of this money has been spent so far? (2) How much of the $18 million allocated for 2006-07 was spent? (3) How much of the $18 million allocated for 2007-08 has been spent so far? (4) Is biotechnology funded from the science budget? (5) If so, what commitments have been funded so far? (6) If not, which section of the budget allocates funds to biotechnology? Hon KIM CHANCE replied: I thank the member for some notice of this question. (1) $4 358 320. (2) $2 900 000. (3) $1 458 320. (4) Yes. (5) Biotechnology strategy, $4 170 000; clinical trials network, $9 946 000; and neurotrauma research program, $8 000 000 - making a total of $22 116 000. (6) Not applicable.
(2) How much of the $18 million allocated for 2006-07 was spent? (3) How much of the $18 million allocated for 2007-08 has been spent so far? (4) Is biotechnology funded from the science budget? (5) If so, what commitments have been funded so far? (6) If not, which section of the budget allocates funds to biotechnology? Hon KIM CHANCE replied: I thank the member for some notice of this question. (1) $4 358 320. (2) $2 900 000. (3) $1 458 320. (4) Yes. (5) Biotechnology strategy, $4 170 000; clinical trials network, $9 946 000; and neurotrauma research program, $8 000 000 - making a total of $22 116 000. (6) Not applicable.
(3) How much of the $18 million allocated for 2007-08 has been spent so far? (4) Is biotechnology funded from the science budget? (5) If so, what commitments have been funded so far? (6) If not, which section of the budget allocates funds to biotechnology? Hon KIM CHANCE replied: I thank the member for some notice of this question. (1) $4 358 320. (2) $2 900 000. (3) $1 458 320. (4) Yes. (5) Biotechnology strategy, $4 170 000; clinical trials network, $9 946 000; and neurotrauma research program, $8 000 000 - making a total of $22 116 000. (6) Not applicable.
(4) Is biotechnology funded from the science budget? (5) If so, what commitments have been funded so far? (6) If not, which section of the budget allocates funds to biotechnology? Hon KIM CHANCE replied: I thank the member for some notice of this question. (1) $4 358 320. (2) $2 900 000. (3) $1 458 320. (4) Yes. (5) Biotechnology strategy, $4 170 000; clinical trials network, $9 946 000; and neurotrauma research program, $8 000 000 - making a total of $22 116 000. (6) Not applicable.
(5) If so, what commitments have been funded so far? (6) If not, which section of the budget allocates funds to biotechnology? Hon KIM CHANCE replied: I thank the member for some notice of this question. (1) $4 358 320. (2) $2 900 000. (3) $1 458 320. (4) Yes. (5) Biotechnology strategy, $4 170 000; clinical trials network, $9 946 000; and neurotrauma research program, $8 000 000 - making a total of $22 116 000. (6) Not applicable.
(6) If not, which section of the budget allocates funds to biotechnology? Hon KIM CHANCE replied: I thank the member for some notice of this question. (1) $4 358 320. (2) $2 900 000. (3) $1 458 320. (4) Yes. (5) Biotechnology strategy, $4 170 000; clinical trials network, $9 946 000; and neurotrauma research program, $8 000 000 - making a total of $22 116 000. (6) Not applicable.
Hon KIM CHANCE replied: I thank the member for some notice of this question. (1) $4 358 320. (2) $2 900 000. (3) $1 458 320. (4) Yes. (5) Biotechnology strategy, $4 170 000; clinical trials network, $9 946 000; and neurotrauma research program, $8 000 000 - making a total of $22 116 000. (6) Not applicable.
I thank the member for some notice of this question. (1) $4 358 320. (2) $2 900 000. (3) $1 458 320. (4) Yes. (5) Biotechnology strategy, $4 170 000; clinical trials network, $9 946 000; and neurotrauma research program, $8 000 000 - making a total of $22 116 000. (6) Not applicable.
(1) $4 358 320. (2) $2 900 000. (3) $1 458 320. (4) Yes. (5) Biotechnology strategy, $4 170 000; clinical trials network, $9 946 000; and neurotrauma research program, $8 000 000 - making a total of $22 116 000. (6) Not applicable.
(2) $2 900 000. (3) $1 458 320. (4) Yes. (5) Biotechnology strategy, $4 170 000; clinical trials network, $9 946 000; and neurotrauma research program, $8 000 000 - making a total of $22 116 000. (6) Not applicable.
(3) $1 458 320. (4) Yes. (5) Biotechnology strategy, $4 170 000; clinical trials network, $9 946 000; and neurotrauma research program, $8 000 000 - making a total of $22 116 000. (6) Not applicable.
(4) Yes. (5) Biotechnology strategy, $4 170 000; clinical trials network, $9 946 000; and neurotrauma research program, $8 000 000 - making a total of $22 116 000. (6) Not applicable.
(5) Biotechnology strategy, $4 170 000; clinical trials network, $9 946 000; and neurotrauma research program, $8 000 000 - making a total of $22 116 000. (6) Not applicable.
(6) Not applicable.
(1) How much of this money has been spent so far? (2) How much of the $18 million allocated for 2006-07 was spent? (3) How much of the $18 million allocated for 2007-08 has been spent so far? (4) Is biotechnology funded from the science budget? (5) If so, what commitments have been funded so far? (6) If not, which section of the budget allocates funds to biotechnology? Hon KIM CHANCE replied: I thank the member for some notice of this question. (1) $4 358 320. (2) $2 900 000. (3) $1 458 320. (4) Yes. (5) Biotechnology strategy, $4 170 000; clinical trials network, $9 946 000; and neurotrauma research program, $8 000 000 - making a total of $22 116 000. (6) Not applicable.
(2) How much of the $18 million allocated for 2006-07 was spent? (3) How much of the $18 million allocated for 2007-08 has been spent so far? (4) Is biotechnology funded from the science budget? (5) If so, what commitments have been funded so far? (6) If not, which section of the budget allocates funds to biotechnology? Hon KIM CHANCE replied: I thank the member for some notice of this question. (1) $4 358 320. (2) $2 900 000. (3) $1 458 320. (4) Yes. (5) Biotechnology strategy, $4 170 000; clinical trials network, $9 946 000; and neurotrauma research program, $8 000 000 - making a total of $22 116 000. (6) Not applicable.
(3) How much of the $18 million allocated for 2007-08 has been spent so far? (4) Is biotechnology funded from the science budget? (5) If so, what commitments have been funded so far? (6) If not, which section of the budget allocates funds to biotechnology? Hon KIM CHANCE replied: I thank the member for some notice of this question. (1) $4 358 320. (2) $2 900 000. (3) $1 458 320. (4) Yes. (5) Biotechnology strategy, $4 170 000; clinical trials network, $9 946 000; and neurotrauma research program, $8 000 000 - making a total of $22 116 000. (6) Not applicable.
(4) Is biotechnology funded from the science budget? (5) If so, what commitments have been funded so far? (6) If not, which section of the budget allocates funds to biotechnology? Hon KIM CHANCE replied: I thank the member for some notice of this question. (1) $4 358 320. (2) $2 900 000. (3) $1 458 320. (4) Yes. (5) Biotechnology strategy, $4 170 000; clinical trials network, $9 946 000; and neurotrauma research program, $8 000 000 - making a total of $22 116 000. (6) Not applicable.
(5) If so, what commitments have been funded so far? (6) If not, which section of the budget allocates funds to biotechnology? Hon KIM CHANCE replied: I thank the member for some notice of this question. (1) $4 358 320. (2) $2 900 000. (3) $1 458 320. (4) Yes. (5) Biotechnology strategy, $4 170 000; clinical trials network, $9 946 000; and neurotrauma research program, $8 000 000 - making a total of $22 116 000. (6) Not applicable.
(6) If not, which section of the budget allocates funds to biotechnology? Hon KIM CHANCE replied: I thank the member for some notice of this question. (1) $4 358 320. (2) $2 900 000. (3) $1 458 320. (4) Yes. (5) Biotechnology strategy, $4 170 000; clinical trials network, $9 946 000; and neurotrauma research program, $8 000 000 - making a total of $22 116 000. (6) Not applicable.
Hon KIM CHANCE replied: I thank the member for some notice of this question. (1) $4 358 320. (2) $2 900 000. (3) $1 458 320. (4) Yes. (5) Biotechnology strategy, $4 170 000; clinical trials network, $9 946 000; and neurotrauma research program, $8 000 000 - making a total of $22 116 000. (6) Not applicable.
I thank the member for some notice of this question. (1) $4 358 320. (2) $2 900 000. (3) $1 458 320. (4) Yes. (5) Biotechnology strategy, $4 170 000; clinical trials network, $9 946 000; and neurotrauma research program, $8 000 000 - making a total of $22 116 000. (6) Not applicable.
(1) $4 358 320. (2) $2 900 000. (3) $1 458 320. (4) Yes. (5) Biotechnology strategy, $4 170 000; clinical trials network, $9 946 000; and neurotrauma research program, $8 000 000 - making a total of $22 116 000. (6) Not applicable.
(2) $2 900 000. (3) $1 458 320. (4) Yes. (5) Biotechnology strategy, $4 170 000; clinical trials network, $9 946 000; and neurotrauma research program, $8 000 000 - making a total of $22 116 000. (6) Not applicable.
(3) $1 458 320. (4) Yes. (5) Biotechnology strategy, $4 170 000; clinical trials network, $9 946 000; and neurotrauma research program, $8 000 000 - making a total of $22 116 000. (6) Not applicable.
(4) Yes. (5) Biotechnology strategy, $4 170 000; clinical trials network, $9 946 000; and neurotrauma research program, $8 000 000 - making a total of $22 116 000. (6) Not applicable.
(5) Biotechnology strategy, $4 170 000; clinical trials network, $9 946 000; and neurotrauma research program, $8 000 000 - making a total of $22 116 000. (6) Not applicable.
(6) Not applicable.
Explore WA Government Data
Search the full archive in the free dashboard, or query programmatically via API.
Explore more
Government Gazette
Appointments, regulatory notices, planning changes.
Hansard
Debates, questions, speeches and sentiment.
Tabled Papers
Reports and documents tabled in Parliament.
Committees
Committee profiles and recent reports.
Regulations
Subsidiary legislation with filters and summaries.
Bills
Proposed laws and parliamentary progress.
Acts
Current WA legislation and summaries.
Explanatory Memoranda
Bills with EMs (text/PDF) available.
Members
MP profiles, party breakdown and rankings.
Pollie Rankings
Data-driven rankings across 19 categories.
Amendment Chains
Track how schemes and regulations evolve over time.